# A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury

> **NCT06091020** · PHASE2 · COMPLETED · sponsor: **Merz Therapeutics GmbH** · enrollment: 123 (actual)

## Conditions studied

- Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

## Interventions

- **BIOLOGICAL:** IncobotulinumtoxinA
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06091020
- **Lead sponsor:** Merz Therapeutics GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-22
- **Primary completion:** 2025-05-07
- **Final completion:** 2025-07-04
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06091020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06091020, "A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06091020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*